Cue Biopharma (CUE)
(Real Time Quote from BATS)
$1.36 USD
-0.05 (-3.55%)
Updated Apr 26, 2024 03:39 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Price, Consensus and EPS Surprise
CUE 1.36 -0.05(-3.55%)
Will CUE be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CUE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CUE
Here's Why Cue Biopharma (CUE) is Poised for a Turnaround After Losing -22.83% in 4 Weeks
Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now
CUE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline
CytomX Therapeutics (CTMX) Lags Q4 Earnings Estimates
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
Other News for CUE
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Biotech Alert: Searches spiking for these stocks today
Cue Energy Secures New Gas Supply Deal
Central Petroleum Expands NT Gas Supply
Forecasting The Future: 4 Analyst Projections For Cue Biopharma